Hsp90 and Hsp40/Erdj3 are required for the expression and anti-apoptotic function of KSHV K1

Oncogene

Volumn 29, Issue 24, 2010, Pages 3532-3544

  Wen, K W ^a,b   Damania, B ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Heat shock proteins; Hsp40; Hsp90; K1; KSHV; Lytic replication

Indexed keywords

17 DEMETHOXY 17 (2 DIMETHYLAMINOETHYLAMINO)GELDANAMYCIN; CHAPERONE; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90BETA; K1 PROTEIN; SMALL INTERFERING RNA; TANESPIMYCIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IC 50; IMMUNOPRECIPITATION; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PURIFICATION;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HERPESVIRUS 8, HUMAN; HSP40 HEAT-SHOCK PROTEINS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; LYMPHOMA, PRIMARY EFFUSION; PROTEIN STRUCTURE, TERTIARY; RNA, SMALL INTERFERING; VIRAL PROTEINS;

HUMAN HERPESVIRUS 8; RODENTIA;

EID: 77953784609     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.124     Document Type: Article

References (54)

1. Berkova Z, Wang S, Wise JF, Maeng H, Ji Y, Samaniego F. (2009). Mechanism of Fas signaling regulation by human herpesvirus 8 K1 oncoprotein. J Natl Cancer Inst 101: 399-411.
2. Bowser BS, DeWire SM, Damania B. (2002). Transcriptional regulation of the K1 gene product of Kaposi's sarcoma-associated herpesvirus. J Virol 76: 12574-12583.
3. Burch AD, Weller SK. (2005). Herpes simplex virus type 1 DNA polymerase requires the mammalian chaperone hsp90 for proper localization to the nucleus. J Virol 79: 10740-10749.
4. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. (1995). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332: 1186-1191.
5. Chandriani S, Ganem D. (2010). Array-based transcript profiling and limiting-dilution RT-PCR analysis identify additional latent genes in KSHV. J Virol Mar (e-pub ahead of print).
6. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM et al. (1994). Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869.
7. Damania B, DeMaria M, Jung JU, Desrosiers RC. (2000). Activation of lymphocyte signaling by the R1 protein of rhesus monkey rhadinovirus. J Virol 74: 2721-2730.
8. Damania B, Li M, Choi JK, Alexander L, Jung JU, Desrosiers RC. (1999). Identification of the R1 oncogene and its protein product from the rhadinovirus of rhesus monkeys. J Virol 73: 5123-5131.
9. Eustace BK, Sakurai T, Stewart JK, Yimlamai D, Unger C, Zehetmeier C et al. (2004). Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasive-ness. Nat Cell Biol 6: 507-514.
10. Field N, Low W, Daniels M, Howell S, Daviet L, Boshoff C et al. (2003). KSHV vFLIP binds to IKK-gamma to activate IKK. J Cell Sci 116: 3721-3728.
11. Fujita N, Sato S, Ishida A, Tsuruo T. (2002). Involvement of Hsp90 in signaling and stability of 3-phosphoinositide-dependent kinase-1. J Biol Chem 277: 10346-10353.
12. Gao T, Newton AC. (2002). The turn motif is a phosphorylation switch that regulates the binding of Hsp70 to protein kinase C. J Biol Chem 277: 31585-31592.
13. Gessain A, Sudaka A, Briere J, Fouchard N, Nicola MA, Rio B et al. (1996). Kaposi sarcoma-associated herpes-like virus (human her-pesvirus type 8) DNA sequences in multicentric Castleman's disease: is there any relevant association in non-human immunodeficiency virus-infected patients? Blood 87: 414-416.
14. Goetz MP, Toft D, Reid J, Ames M, Stensgard B, Safgren S et al. (2005). Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer. J Clin Oncol 23: 1078-1087. (Pubitemid 46202262)
15. Hollingshead M, Alley M, Burger AM, Borgel S, Pacula-Cox C, Fiebig HH et al. (2005). in vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino- 17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative. Cancer Chemother Pharmacol 56: 115-125.
16. Ivy PS, Schoenfeldt M. (2004). Clinical trials referral resource. Current clinical trials of 17-AG and 17-DMAG. Oncology (Williston Park) 18: 610-615 619-620.
17. Lagunoff M, Ganem D. (1997). The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus. Virology 236: 147-154.
18. Lagunoff M, Majeti R, Weiss A, Ganem D. (1999). Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci USA 96: 5704-5709.
19. Le Boeuf F, Houle F, Huot J. (2004). Regulation of vascular endothelial growth factor receptor 2-mediated phosphorylation of focal adhesion kinase by heat shock protein 90 and Src kinase activities. J Biol Chem 279: 39175-39185.
20. Lee BS, Alvarez X, Ishido S, Lackner AA, Jung JU. (2000). Inhibition of intracellular transport of B cell antigen receptor complexes by Kaposi's sarcoma-associated herpesvirus K1. J Exp Med 192: 11-21.
21. Lee BS, Connole M, Tang Z, Harris NL, Jung JU. (2003). Structural analysis of the Kaposi's sarcoma-associated herpesvirus K1 protein. J Virol 77: 8072-8086.
22. Lee BS, Lee SH, Feng P, Chang H, Cho NH, Jung JU. (2005). Characterization of the Kaposi's sarcoma-associated herpesvirus K1 signalosome. J Virol 79: 12173-12184. (Pubitemid 41346079)
23. Lee H, Guo J, Li M, Choi JK, DeMaria M, Rosenzweig M et al. (1998a). Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus. Mol Cell Biol 18: 5219-5228.
24. Lee H, Veazey R, Williams K, Li M, Guo J, Neipel F et al. (1998b). Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nat Med 4: 435-440.
25. Lewis J, Devin A, Miller A, Lin Y, Rodriguez Y, Neckers L et al. (2000). Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation. J Biol Chem 275: 10519-10526.
26. Li W, Li Y, Guan S, Fan J, Cheng CF, Bright AM et al. (2007). Extracellular heat shock protein-90alpha: linking hypoxia to skin cell motility and wound healing. EMBO J 26: 1221-1233.
27. Livingston CM, DeLuca NA, Wilkinson DE, Weller SK. (2008). Oligomerization of ICP4 and rearrangement of heat shock proteins may be important for herpes simplex virus type 1 prereplicative site formation. J Virol 82: 6324-6336.
28. Nathan DF, Lindquist S. (1995). Mutational analysis of Hsp90 function: interactions with a steroid receptor and a protein kinase. Mol Cell Biol 15: 3917-3925.
29. Ohji G, Hidayat S, Nakashima A, Tokunaga C, Oshiro N, Yoshino K et al. (2006). Suppression of the mTOR-raptor signaling pathway by the inhibitor of heat shock protein 90 geldanamycin. J Biochem 139: 129-135.
30. Pang Q, Keeble W, Christianson TA, Faulkner GR, Bagby GC. (2001). FANCC interacts with Hsp70 to protect hematopoietic cells from IFN-gamma/TNF-alpha- mediated cytotoxicity. EMBO J 20: 4478-4489.
31. Pearl LH, Prodromou C. (2006). Structure and mechanism of the Hsp90 molecular chaperone machinery. Annu Rev Biochem 75: 271-294.
32. Pedersen CB, Bross P, Winter VS, Corydon TJ, Bolund L, Bartlett K et al. (2003). Misfolding, degradation, and aggregation of variant proteins. The molecular pathogenesis of short chain acyl-CoA dehydrogenase (SCAD) deficiency. J Biol Chem 278: 47449-47458.
33. Picard D. (2004). Hsp90 invades the outside. Nat Cell Biol 6: 479-480.
34. Picard D, Khursheed B, Garabedian MJ, Fortin MG, Lindquist S, Yamamoto KR. (1990). Reduced levels of hsp90 compromise steroid receptor action in vivo. Nature 348: 166-168.
35. Prakash O, Swamy OR, Peng X, Tang ZY, Li L, Larson JE et al. (2005). Activation of Src kinase Lyn by the Kaposi sarcoma-associated herpesvirus K1 protein: implications for lymphomagen-esis. Blood 105: 3987-3994.
36. Prakash O, Tang ZY, Peng X, Coleman R, Gill J, Farr G et al. (2002). Tumorigenesis and aberrant signaling in transgenic mice expressing the human herpesvirus-8 K1 gene. J Natl Cancer Inst 94: 926-935.
37. Rigaut G, Shevchenko A, Rutz B, Wilm M, Mann M, Seraphin B. (1999). A generic protein purification method for protein complex characterization and proteome exploration. Nat Biotechnol 17: 1030-1032.
38. Samaniego F, Pati S, Karp JE, Prakash O, Bose D. (2001). Human herpesvirus 8 K1-associated nuclear factor-kappa B-dependent promoter activity: role in Kaposi's sarcoma inflammation? J Natl Cancer Inst Monogr 28: 15-23.
39. Sato S, Fujita N, Tsuruo T. (2000). Modulation of Akt kinase activity by binding to Hsp90. Proc Natl Acad Sci USA 97: 10832-10837.
40. Schmitt E, Gehrmann M, Brunet M, Multhoff G, Garrido C. (2007). Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy. J Leukoc Biol 81: 15-27. (Pubitemid 46021247)
41. Shen Y, Hendershot LM. (2005). ERdj3, a stress-inducible endoplas-mic reticulum DnaJ homologue, serves as a cofactor for BiP's interactions with unfolded substrates. Mol Biol Cell 16: 40-50.
42. Shinozaki F, Minami M, Chiba T, Suzuki M, Yoshimatsu K, Ichikawa Y et al. (2006). Depletion of hsp90beta induces multiple defects in B cell receptor signaling. J Biol Chem 281: 16361-16369.
43. Sidera K, Samiotaki M, Yfanti E, Panayotou G, Patsavoudi E. (2004). Involvement of cell surface HSP90 in cell migration reveals a novel role in the developing nervous system. J Biol Chem 279: 45379-45388.
44. Smith DF, Whitesell L, Nair SC, Chen S, Prapapanich V, Rimerman RA. (1995). Progesterone receptor structure and function altered by geldanamycin, an hsp90-binding agent. Mol Cell Biol 15: 6804-6812.
45. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P et al. (1995). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86: 1276-1280.
46. Tomlinson CC, Damania B. (2004). The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway. J Virol 78: 1918-1927. (Pubitemid 38176723)
47. Tomlinson CC, Damania B. (2008). Critical role for endocytosis in the regulation of signaling by the Kaposi's sarcoma-associated herpes-virus K1 protein. J Virol 82: 6514-6523.
48. Trentin L, Frasson M, Donella-Deana A, Frezzato F, Pagano MA, Tibaldi E et al. (2008). Geldanamycin-induced Lyn dissociation from aberrant Hsp90-stabilized cytosolic complex is an early event in apoptotic mechanisms in B-chronic lymphocytic leukemia. Blood 112: 4665-4674.
49. Wang L, Dittmer DP, Tomlinson CC, Fakhari FD, Damania B. (2006). Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus. Cancer Res 66: 3658-3666.
50. Wang L, Wakisaka N, Tomlinson CC, DeWire SM, Krall S, Pagano JS et al. (2004). The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors. Cancer Res 64: 2774-2781.
51. Wang S, Wang S, Maeng H, Young DP, Prakash O, Fayad LE et al. (2007). K1 protein of human herpesvirus 8 suppresses lymphoma cell Fas-mediated apoptosis. Blood 109: 2174-2182.
52. Whitesell L, Sutphin P, An WG, Schulte T, Blagosklonny MV, Neckers L. (1997). Geldanamycin-stimulated destabilization of mutated p53 is mediated by the proteasome in vivo. Oncogene 14: 2809-2816.
53. Xu W, Yuan X, Jung YJ, Yang Y, Basso A, Rosen N et al. (2003). The heat shock protein 90 inhibitor geldanamycin and the ErbB inhibitor ZD1839 promote rapid PP1 phosphatase-dependent inactivation of AKT in ErbB2 overexpressing breast cancer cells. Cancer Res 63: 7777-7784.
54. Zhang C, Guy CL. (2005). Co-immunoprecipitation of Hsp101 with cytosolic Hsc70. Plant Physiol Biochem 43: 13-18.